Puma Biotechnology | PBYI - EPS Earnings Per Share


Puma Biotechnology reported $0.41 in EPS Earnings Per Share for its fiscal quarter ending in September of 2024.





Eps Change Date
Agios Pharmaceuticals USD -1.69 0.17 Mar/2026
Alnylam Pharmaceuticals USD 1.99 0.74 Mar/2026
Amgen USD 5.15 0.14 Mar/2026
Biogen USD 3.57 1.58 Mar/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Daiichi Sankyo JPY 48.75 1.96 Mar/2026
Esperion Therapeutics USD 0.26 0.42 Dec/2025
Exelixis USD 0.87 0.1 Mar/2026
Gilead Sciences USD 2.03 0.17 Mar/2026
Glaxosmithkline GBP 0.62 0.41 Mar/2026
Incyte USD 1.81 0.01 Mar/2026
MacroGenics USD -0.58 0.36 Mar/2026
Moderna USD -3.4 1.29 Mar/2026
Novartis USD 1.99 0.04 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
PTC Therapeutics USD -0.03 1.64 Mar/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Roche Holding CHF 8.37 2.95 Dec/2025
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sarepta Therapeutics USD 3.16 6.74 Mar/2026
Takeda JPY -15.56 81.3 Mar/2026
TG Therapeutics USD 0.12 0.02 Mar/2026
Ultragenyx Pharmaceutical USD -1.84 0.55 Mar/2026
Vanda Pharmaceuticals USD -0.09 0 Dec/2024
Vertex Pharmaceuticals USD 4.47 0.56 Mar/2026